Helport AI Ltd
HPAI Nasdaq Services-Prepackaged Software Financials FY2022–FY2025
What Helport AI Ltd does
No business description yet.
- Legal name
- Helport AI Ltd
- Fiscal year ends
- June 30, 2025
- Latest annual report
- 20-F · Nov 17, 2025
- Accession · CIK
- 0001213900-25-111531
0002001699
Revenue and margins
Helport AI Ltd had $34.9M of revenue in fiscal 2025, up 17.9% on the year before.
Net income and earnings per share
From fiscal 2022 to 2025, diluted EPS grew −97.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Helport AI Ltd returned — to shareholders in fiscal 2025. The diluted share count rose 23.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Helport AI Ltd can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $0.0M | $0.1M | $2.6M | $0.2M |
| Interest coverage | — | — | — | 164.5x |
| Current ratio | — | 1.1x | 1.8x | 1.2x |
| Quick ratio | — | 1.1x | 1.8x | 1.2x |
| Total assets | — | $18.8M | $27.2M | $37.2M |
| Total liabilities | — | $13.1M | $14.1M | $19.7M |
| Shareholders' equity | $0.9M | $5.7M | $13.1M | $17.5M |
| Net debt (− = net cash) | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✕ | ✕ | ✓ | ✓ |
| Return on assets rose | — | — | ✓ | ✕ |
| Cash from operations exceeds net income | ✕ | ✕ | ✕ | ✓ |
| Debt fell relative to assets | — | — | — | — |
| Current ratio rose | — | — | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✓ | ✕ |
| Revenue rose relative to assets | — | — | ✓ | ✕ |
| F-score | — / 3 | — / 5 | 7 / 8 | 3 / 8 |
| Accruals ratio | — | 28.1% | 10.2% | −22.4% |
| Altman Z'' | — | 4.08 | 7.37 | 3.56 |
4 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.7M | $12.7M | $29.6M | $34.9M |
| Gross profit | $1.4M | $7.8M | $18.6M | $19.1M |
| Research and development | — | $0.4M | $4.3M | $6.3M |
| Operating income | $1.0M | $5.8M | $9.2M | $2.7M |
| Interest expense | — | — | — | $0.0M |
| Pretax income | $1.0M | $5.8M | $9.0M | $2.4M |
| Income tax | $0.2M | $1.0M | $1.6M | $0.5M |
| Net income | $0.8M | $4.8M | $7.4M | $1.9M |
| Diluted EPS | $5,269.00 | $0.16 | $0.24 | $0.05 |
| Diluted shares | 0.00B | 0.03B | 0.03B | 0.04B |
| Cash flow | ||||
| Cash from operations | −$0.1M | −$0.5M | $5.0M | $9.1M |
| Stock-based compensation | — | — | — | $0.6M |
| Balance sheet | ||||
| Cash and short-term investments | $0.0M | $0.1M | $2.6M | $0.2M |
| Current assets | — | $14.7M | $24.8M | $23.8M |
| Current liabilities | — | $13.1M | $14.1M | $19.1M |
| Intangible assets | — | $4.1M | $2.4M | $12.7M |
| Total assets | — | $18.8M | $27.2M | $37.2M |
| Total liabilities | — | $13.1M | $14.1M | $19.7M |
| Shareholders' equity | $0.9M | $5.7M | $13.1M | $17.5M |
| Margins | ||||
| Gross margin | 53.3% | 61.6% | 62.8% | 54.9% |
| Operating margin | 36.8% | 45.5% | 31.1% | 7.9% |
| Net margin | 30.8% | 37.8% | 24.9% | 5.3% |
| Returns | ||||
| Return on capital employed | — | 101.9% | 70.5% | 15.2% |
| Return on equity | 94.5% | 146.9% | 78.7% | 12.2% |
| Return on assets | — | 25.6% | 32.1% | 5.8% |
| Return on tangible equity | 94.5% | 300.8% | 69.3% | 38.8% |
| Growth | ||||
| Revenue growth | — | 377.1% | 132.4% | 17.9% |
| Net income growth | — | 485.7% | 53.1% | −74.8% |
| EPS growth | — | −100.0% | 50.0% | −79.2% |
| Share count change | — | 15,140,300.0% | 0.0% | 23.6% |
| Financial health | ||||
| Interest coverage | — | — | — | 164.5x |
| Current ratio | — | 1.1x | 1.8x | 1.2x |
| Quick ratio | — | 1.1x | 1.8x | 1.2x |
| Capital allocation | ||||
| Stock comp / revenue | — | — | — | 1.7% |
| Quality scores | ||||
| Piotroski F-score | — | — | 7.0 | 3.0 |
| Altman Z'' | — | 4.1 | 7.4 | 3.6 |
| Accruals ratio | — | 28.1% | 10.2% | −22.4% |
Source: SEC EDGAR XBRL filings (CIK 0002001699). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.